Efficacy and safety of botulinum toxin injection for occipital neuralgia: a systematic review
Anaesthesia, Pain & Intensive Care · 04.05.2026 · 30 (3) · 357-364
DOI: 10.35975/apic.v30i3.3175 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Anaesthesia, Pain & Intensive Care, online erschienen am 04.05.2026. Verfasst von Yusak Mangara Tua Siahaan und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Occipital neuralgia (ON) is a rare condition characterized by stabbing pain along the greater and lesser occipital nerves. Standard treatments often provide limited relief. Botulinum toxin type A (BoNT-A), previously used for headache, is being explored as a potential treatment for ON. This study aims to assess its safety and effectiveness. Methodology: A comprehensive literature search was carried out in PubMed, EuropePMC, ScienceDirect, and Google Scholar using keywords such as “Occipital Neuralgia,” “Greater Occipital Nerve,” “Botulinum Toxin A,” “Onabotulinum Toxin A,” “Botulinum Toxin Type-A,” “BoNT-A,” “Botox,” and “Pain,” covering publications up to April 2025. The primary outcome was the Visual Analog Scale (VAS) score, while secondary outcomes included reported adverse events.
Results
This systematic review encompasses six studies with 69 participants. Despite variations in follow-up durations (2, 4, and 12 weeks), all studies reported significant reductions in VAS. Furthermore, no adverse effects related to BoNT-A administration were observed.
Conclusion
In summary, this review indicates that BoNT-A effectively alleviates pain in occipital neuralgia, with benefits observable as early as two weeks post-injection and lasting up to 12 weeks. However, due to variations in dosage, injection techniques, and study methodologies, further well-controlled trials are necessary to confirm its efficacy. Keywords: Occipital Neuralgia, Botulinum Toxin Type-A, Pain Citation: Siahaan YMT, Pradhana TM, Arjuna YYE, Hartoyo V, Purnomo AE, Darmawan RO. Efficacy and Safety of Botulinum Toxin Injection for Occipital Neuralgia: A Systematic Review. Anaesth. pain intensive care 2026;30(3):357-364. DOI: 10.35975/apic.v30i3.3175 Recevised: May 29, 2025; Revised: August 29, 2025; Accepted: December 15, 2026
Zitieren
APA
Siahaan, Y. M. T., Pradhana, T. M., Arjuna, Y. Y. E., Hartoyo, V., Purnomo, A. E., & Darmawan, R. O. (2026). Efficacy and safety of botulinum toxin injection for occipital neuralgia: a systematic review. Anaesthesia, Pain & Intensive Care, 30(3), 357-364. https://doi.org/10.35975/apic.v30i3.3175
Vancouver
Siahaan YMT, Pradhana TM, Arjuna YYE, Hartoyo V, Purnomo AE, Darmawan RO. Efficacy and safety of botulinum toxin injection for occipital neuralgia: a systematic review. Anaesthesia, Pain & Intensive Care. 2026;30(3):357-364. doi:10.35975/apic.v30i3.3175
BibTeX
@article{Siahaan2026,
author = {Siahaan, Yusak Mangara Tua and Pradhana, Tasya Meidy and Arjuna, Yang Yang Endro and Hartoyo, Vinson and Purnomo, Alexander Erick and Darmawan, Rosaria Oktafiani},
title = {Efficacy and safety of botulinum toxin injection for occipital neuralgia: a systematic review},
journal = {Anaesthesia, Pain & Intensive Care},
year = {2026},
volume = {30},
number = {3},
pages = {357--364},
doi = {10.35975/apic.v30i3.3175}
}
EUVIMED